Status:

NOT_YET_RECRUITING

Acupuncture Versus Compound Diclofenac Sodium for Pain Relief in Non-Traumatic Acute Abdominal

Lead Sponsor:

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

Conditions:

Acute Abdominal Pain

Acupuncture Therapy

Eligibility:

All Genders

16-75 years

Phase:

PHASE1

PHASE2

Brief Summary

The investigators designed this clinical study to evaluate the efficacy and safety of semi-standardized acupuncture and moxibustion combined with compound diclofenac sodium injection in the emergency ...

Detailed Description

This study is a prospective, parallel-controlled, open-label randomized controlled trial (RCT). The Numeric Rating Scale (NRS) was used to assess pain intensity. The primary outcome measure was the di...

Eligibility Criteria

Inclusion

  • The diagnostic criteria of NTAA were as follows: ① abdominal pain was the main symptom; ② The onset time was less than 1 week; ③ The cause of abdominal pain could be traced to intra-abdominal abdominal wall chest or systemic diseases;
  • Patients with NRS scores ≥4 (mild pain and above) were evaluated before inclusion; (3)16 years \< age \<75 years;
  • (4)Those who were considered not to need surgery within 2 hours after initial assessment by a specialist.

Exclusion

  • Participants meeting any of the following criteria were excluded from the study:
  • Acute abdomen caused by trauma;
  • Super sudden diseases (e.g. acute myocardial infarction rupture of abdominal aortic aneurysm pulmonary embolism aortic dissection pericardial tamponade);
  • Emergent conditions requiring surgical treatment within 3 hours (e.g. rupture of liver cancer ectopic pregnancy ischemic bowel disease severe acute cholangitis peritonitis with septic shock);
  • Extremely severe pain (NRS ≥ 8) with an undetermined diagnosis and requiring further assessment for a super sudden disease;
  • Inability to select acupuncture points due to skin injury or ulceration at Zusanli (ST36) on the lower limb;
  • Induration or infection at the hip injection site;
  • Patients with altered consciousness mental illness other severe chronic diseases or those who are unlikely to cooperate with acupuncture treatment;
  • Contraindications to Western medicine:
  • Known allergies to diclofenac sodium or acetaminophen; ②History of asthma urticaria or allergic reactions induced by aspirin or other NSAIDs.
  • Undergoing coronary artery bypass grafting (CABG) surgery. ④History of gastrointestinal bleeding or perforation following non-steroidal anti-inflammatory drugs (NSAIDs).
  • Active gastrointestinal ulcers or bleeding or a history of recurrent ulcers or bleeding.
  • Severe heart failure.
  • Use of any pain medication or acupuncture within the past 6 hours;
  • Previous participation in this study;
  • Pregnant or lactating individuals.

Key Trial Info

Start Date :

June 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

176 Patients enrolled

Trial Details

Trial ID

NCT06982755

Start Date

June 1 2025

End Date

December 31 2026

Last Update

May 21 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.